These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7553648)

  • 1. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
    Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
    Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].
    Péterfia B; Hollósi P; Szilák L; Timár F; Paku S; Jeney A; Kovalszky I
    Magy Onkol; 2006; 50(2):115-20. PubMed ID: 16888674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
    Viklund L; Loo BM; Hermonen J; El-Darwish K; Jalkanen M; Salmivirta M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):146-52. PubMed ID: 11779146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
    Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
    Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
    Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
    Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of syndecan in transformed mouse keratinocytes.
    Inki P; Gomez M; Quintanilla M; Cano A; Jalkanen M
    Lab Invest; 1992 Aug; 67(2):225-33. PubMed ID: 1501448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells.
    Salmivirta M; Mali M; Heino J; Hermonen J; Jalkanen M
    Exp Cell Res; 1994 Nov; 215(1):180-8. PubMed ID: 7957667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes.
    Inki P; Larjava H; Haapasalmi K; Miettinen HM; Grenman R; Jalkanen M
    Eur J Cell Biol; 1994 Feb; 63(1):43-51. PubMed ID: 8005104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.
    Sneed TB; Stanley DJ; Young LA; Sanderson RD
    Cell Immunol; 1994 Feb; 153(2):456-67. PubMed ID: 8118875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
    Dobra K; Nurminen M; Hjerpe A
    Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells.
    Ohtake T; Fujimoto Y; Ikuta K; Saito H; Ohhira M; Ono M; Kohgo Y
    Br J Cancer; 1999 Oct; 81(3):393-403. PubMed ID: 10507762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of proteoglycan core proteins in human bone marrow stroma.
    Schofield KP; Gallagher JT; David G
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements.
    Brockstedt U; Dobra K; Nurminen M; Hjerpe A
    Exp Cell Res; 2002 Apr; 274(2):235-45. PubMed ID: 11900484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
    Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
    Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
    Schiller JH; Bittner G
    Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan in carcinomas produced from transformed epithelial cells in nude mice.
    Inki P; Kujari H; Jalkanen M
    Lab Invest; 1992 Mar; 66(3):314-23. PubMed ID: 1538586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.